Shanghai Allist Pharmaceuticals Co., Ltd. (SHSE: 688578)
Health Care · Pharmaceuticals · CN
CN¥116.50
-3.24% today · +24.2% 1Y
Shanghai Allist Pharmaceuticals Co., Ltd. (SHSE: 688578) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $7.80B and employs 1,989 people.
Over the last twelve months the share price has gained 24.2%, trading between 78.82 and 138.30.
Tweenvest scores Shanghai Allist Pharmaceuticals Co., Ltd. across four factors: quality 77/100, value 61/100, growth 100/100, dividend 20/100. Its strongest factor is growth.
688578 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $7.80B
- Revenue (TTM)
- $902.92M
- P/E
- 19.62
- EPS
- 5.94
- Dividend yield
- 1.03%
- Beta (5Y)
- 0.02
- 52-week high
- CN¥138.30
- 52-week low
- CN¥78.82
- Avg volume (3M)
- —
- Shares outstanding
- 450.00M
- Employees
- 1,989
- Next earnings
- —
About Shanghai Allist Pharmaceuticals Co., Ltd.
Established in 2004, Shanghai Allist Pharmaceuticals Co., Ltd. is a Chinese enterprise dedicated to the innovation and development of medicinal products. Headquartered in Shanghai, the company focuses its efforts on creating therapeutic agents specifically for the treatment of various tumor and cancer-related conditions.
- Founded
- 2004
- Listed since
- Dec 2, 2020
- Exchange
- Shanghai Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,240.63 | -1.18% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $271.52 | +0.47% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $150.55 | -1.31% |
| Roche Holding AGSWX: ROP | $373.91B | CHF369.10 | -1.73% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £120.32 | -1.70% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $27.93 | -0.50% |
Figures last refreshed Aug 18, 2026.